CN202083693U - Test paper for detecting anti-ribosomal P0 antibody by adopting colloidal gold chromatographic assay - Google Patents
Test paper for detecting anti-ribosomal P0 antibody by adopting colloidal gold chromatographic assay Download PDFInfo
- Publication number
- CN202083693U CN202083693U CN2011200310809U CN201120031080U CN202083693U CN 202083693 U CN202083693 U CN 202083693U CN 2011200310809 U CN2011200310809 U CN 2011200310809U CN 201120031080 U CN201120031080 U CN 201120031080U CN 202083693 U CN202083693 U CN 202083693U
- Authority
- CN
- China
- Prior art keywords
- antibody
- ribosomes
- layer
- test paper
- pad
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Landscapes
- Peptides Or Proteins (AREA)
Abstract
The utility model discloses test paper for detecting an anti-ribosomal P0 antibody by adopting colloidal gold chromatographic assay. The test paper comprises a sample pad, a combined pad, a nitrocellulose coating film and an absorbent pad, wherein one side of the sample pad, one side of the combined pad, one side of the nitrocellulose coating film and one side of the absorbent pad are sequentially adhered to a bottom plate towards the other side of the bottom plate, the combined pad is coated with a gold-labeled antibody layer a and a gold-labeled antibody layer b, a detection line and a quality control line are arranged on the nitrocellulose coating film, the detection line is coated with a ribosomal P0 antigen protein layer, and the quality control line is coated with a gold-labeled antibody layer c. In the utility model, the indirect immunoassay is adopted and ribosomal P0 antigen proteins are introduced to optimize the process of the combined pad and the sample pad so as to realize the high-sensitivity, high-specificity and high-accuracy detection performance of the anti-ribosomal P0 antibody, so that a reference evidence is provided for the assistant diagnosis of inchoate systemic lupus erythematosus.
Description
Technical field
The utility model belongs to the medical immunology application, is specifically related to utilize the test paper of the anti-ribosomes P0 of colloidal gold immunochromatographimethod technology for detection antibody.
Background technology
Anti-ribosomes P protein antibodies is considered to systemic loupus erythematosus (systemic lupus erythematosus, SLE) specific antibody (Ghirardello A, Doria A, Zamp ieri S, et al.Antiribosomal P p rotein antibodies detected by immunoblotting in patients with connective tissue diseases:their specificity for systemic lupus erythematosus and as sociation with anticardiolip in antibodies[J] .Ann Rheum D is, 2000,59:975-981.), its at antigen be 3 kinds of ribosomes phosphoric acid albumen P0, P1 and P2.
Previously research thinks that the impair relations of anti-ribosomes P protein antibodies and SLE patient's central nervous system is close, is the sign of neural spiritual lupus; Also the someone reports and thinks, itself and relevant (Yalaoui1 S such as state of an illness activity and kidney, liver damage, Gorgi1 Y, Hajri2 R, et al.Autoantibodies to ribosomal P proteins in systemic lupus erythematosus [J] .JointB one Spine, 2002,69:173-176.).
Domestic report ((Wu Zhenbiao, Zhu Ping, detection and clinical meaning [J] cell and the molecular immunology magazine of the anti-ribosomes P of Patients with SLE serum protein antibodies such as Wang Yanhong, 2005,21 (1) 120-122).) employing European Union immune spot-ing, the anti-ribosomes P of 150 routine SLE patients serums protein antibodies is measured, positive rate is 24%, between document [Arnett PC, Reveille JD, Moutsopoulos HM, et al.Ribosomal P autoantibodies in systemic lupus erythematosus:frequencies in differentethnic groups and immunogenetics associations [J] .A rthritis Rheum, 1996,39:1833-1839.] report 10%～40% between, be higher than American-European crowd's 13% positive rate.
Yalaoui1 S etc. thinks, the correlativity of the neural moral damage of anti-ribosomes P protein antibodies and SLE is the strongest, and be called " mark " (Yalaoui1 S of the neural moral damage of SLE, Gorgi1 Y, Hajri2 R, et al.Autoantibodies to ribosomal P proteins in systemic lupus erythematosus [J] .JointB one Spine, 2002,69:173-176.), this has participated in process [the Isshi K of neural moral damage with the anti-neuronal antibodies of itself and all the other in different links, Hirohata S.Differential roles of the anti ribosomal P antibody and anti neuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus[J] .A rthritisRheum, 1998,41:1819-1827.] relevant.
The research report is arranged afterwards, and anti-ribosomes P protein antibodies is relevant with SLE patient's liver damage and lupus nephritis, and thinks that anti-ribosomes P protein antibodies is the virulence factor that causes hepatocellular injury.Anti-P protein antibodies is also relevant with SLE patient's state of an illness activity, the positive rate of this antibody of patient of state of an illness activity and titre rising [Chindalore V, NeasB, ReichlinM.The association between anti ribosomal P antibodies and active nephritis in systemic lupus erythematosus[J] .Clin Imm uno Imm unopathol, 1998,87:292-296.].
SLE patient exist significant lymphocyte subgroup and Tumor Necrosis Factor Receptors unusual, and it is relevant with getting involved of internal organs [left towering, Ma Dongchu, Zuo Wei etc. the variation of lupus nephritis patient's lymphocyte subgroup ratio and immunoglobulin level [J]. cell and molecular immunology magazine, 2002,18 (1): 46-48.].
[ReichlinM such as Reichlin, BroylesTF, H ¨ u bscher0, et al.Antibodies to ribosomalP p roteins are more p revalent in juvenile onset systemic lupus erythematosus than in the adult disease[J] .A rthritis Rheum, 1999,42:69-75.] report, anti-ribosomes P protein antibodies is the positive rate height in the SLE patient of youth's morbidity.Find that also the positive rate of anti-ribosomes P protein antibodies is relevant with the positive rate of anti-Sm, anti-RNP antibody and anti-dsDNA antibody, and does not have correlativity with anti-SSA, anti-SSB antibody and ANA, publishing in the newspaper with Ghirardello A previously conforms to.
Anti-ribosomes P albumen is not present in other autoimmune diseases, and the autoantibody of anti-ribosomes phosphoprotein (Rib-P) is considered to that SLE is had high degree of specificity.Big subunit (60S) the acid phosphorus albumen of ribosomes compound, P0 (38kD), P1 (19kD) and P2 (17kD) take on autoantigen.P0 is considered to main target antigen, because nearly all anti-ribosomes serum antigen-reactive therewith all, so the utility model adopts the mode of expressing the humanization genetic engineering bacterium to produce main target antigen P0.
Anti-ribosomes P antibody is mainly found in patient SLE of active stage.The most important thing is particularly to suffer from patient SLE of serious low blood pressure, ephritis and hepatitis at these antibody and SLE, between have correlativity.
The method of the anti-nuclear membrane glycoprotein of detection (ribosomes P0) antibody that present laboratory is commonly used mainly contains enzyme-linked immunosorbent test (enzyme linked immunosorbent assay, ELISA), Western blot (immunoblotting test, IBT), linear immunoassay (Line immunoassay, LIA), SRID (immunodiffusion) [Rayno K, Reichlin M.Evaluation of Assays for the detection of autoantibodies to the ribosomal p p roteins[J] .Clini Imm unol, 2000,95:99-103.].
Though Western blot combines the high resolution of SDS-PAGE and the high specific and the susceptibility of ELISA method, the operation relative complex, and reagent has stronger toxicity and contaminative.
Linear immunoassay is mainly used in the examination of the big class of disease, and specific aim is relatively poor relatively, also is not suitable for the detection of high flux sample simultaneously.
The ELISA method detects and can be used for high flux sample mensuration, and sensitivity is also higher, is extensively approved at present, but operate more loaded down with trivial detailsly, need repeatedly application of sample and washing, and be subject to the influence of temperature and incubation conditions, in specialized laboratory, operate, bring inconvenience to experiment.
Therefore SRID also is restricted clinically because susceptibility is relatively poor, and judged result depends on operator's experience, and incubation time is longer, is not suitable for the detection of high flux sample.
The anti-ribosomes P0 of commercialization in the market antibody assay kit is mainly Western blot, running program is loaded down with trivial details, finish whole experiment and need about three hours, also need the professional immunological technique personnel operation that in the laboratory, experimentizes, be subject to the influence of environmental baseline factors such as all temps and incubation time simultaneously, test is brought inconvenience.
Colloidal gold chromatography is applied in the anti-ribosomes P0 detection of antibodies.Colloidal gold immunity chromatography (gold-immunochromatography assay, GICA) be to use colloidal gold-labeled method, with collaurum as tracer, with the fibre strip chromatographic material is solid phase, make sample solution swimming on chromatography strip by capillary effect, make that immune response takes place the acceptor (as antigen or antibody) at determinand on determinand in the sample and the pad, and immune response takes place and be trapped with antigen (or antibody) on the fibre strip chromatographic material, and then form macroscopic aubergine band, obtain experimental result intuitively, reach the purpose (Sikowicz G et al.One-step chromatographic immunoassay for qualitative determination of choricogonadotropin in urine.Clin Chem.1990 (36) 1579-1586.) of fast detecting.During use only with sample pipetting volume on sample pad, just situation occurred and judge the yin and yang attribute result in several minutes according to aubergine band on the detection line.Advantages such as compare with other detection methods, detection time is short, only needs 5～10 minutes, and operating personnel need not training, and are easy and simple to handle, quick, need not cryopreservation, and accumulating is convenient.
Aspect autoimmune disease, occurred some at present on the foreign market and detected the test strips product of autoimmune disease, but the colloid gold immune test paper of anti-ribosomes P0 antibody does not at home and abroad still come out on the market.
The utility model content
Technical problem to be solved in the utility model is in order to overcome above methodological deficiency, colloidal gold chromatography is applied in the anti-ribosomes P0 detection of antibodies, first ribosomes P0 antigen protein is applied in the colloidal gold chromatography simultaneously, the employing indirect method realizes the anti-ribosomes P0 antibody test in the blood, realize the detection performance of high special, high sensitivity, high accuracy, rapid screening goes out the positive sample of anti-ribosomes P0 antibody, can be fast, assistant diagnosis system lupus erythematosus easily.。
Technical problem to be solved in the utility model is to provide the anti-ribosomes P0 of a kind of colloidal gold chromatography antibody test test paper.
Technical problem to be solved in the utility model can be achieved through the following technical solutions:
The anti-ribosomes P0 of colloidal gold chromatography antibody test test paper, include sample pad, pad, cellulose nitrate coated film, adsorptive pads, described sample pad, pad, cellulose nitrate coated film, adsorptive pads are sticked on the described base plate to the opposite side of described base plate successively by a side of base plate, and its special disease is:
Described pad is coated with golden labeling antibody a layer and golden labeling antibody b layer;
Described cellulose nitrate coated film is provided with detection line and nature controlling line, and described detection line is coated with ribosomes P0 antigen protein layer, and described nature controlling line is coated with golden labeling antibody c layer.
Further, the antibody A in the described golden labeling antibody a layer is one or more in anti-human IgG monoclonal antibody, anti-human IgG polyclonal antibody, staphylococcal protein A (SPA), the streptococcal protein G (Protein G).
Described anti-human IgG polyclonal antibody is a kind of in mouse source, Ma Yuan, Yang Yuan, rabbit source or the cavy source.
Described anti-human IgG monoclonal antibody is a kind of in mouse source or the rabbit source.
Antibody A in the described golden labeling antibody a layer is preferably staphylococcal protein A.
Antibody B in the described golden labeling antibody b layer and the antibody C in the golden labeling antibody c layer simultaneously or be a kind of in monoclonal antibody or the polyclonal antibody simultaneously, specificity can take place in conjunction with the formation immune complex in the antibody C in antibody B in the wherein golden labeling antibody b layer and the golden labeling antibody c layer.
Described polyclonal antibody is a kind of in mouse source, Ma Yuan, Yang Yuan, rabbit source or the cavy source, and monoclonal antibody is a kind of in mouse source or the rabbit source.
Antibody B in the described golden labeling antibody b layer is preferably rabbit igg, and the antibody C in the correspondingly golden labeling antibody c layer is preferably goat anti-rabbit igg.
The ribosomes P0 antigen protein layer of ribosomes P0 antigen protein layer for obtaining of bag quilt on the described detection line by the prokaryotic expression cloned gene.
Described ribosomes P0 antigen protein is the recombinant protein that cloned gene obtained by escherichia coli prokaryotic expression.
The sample of described sample pad is from human serum, blood plasma, whole blood sample.
The monoclonal antibody of using according to the utility model can by by Kohler etc. (Continuous cultures of fused cells secreting antibody of predefined specificity[J] .Nature, 1975 (256): 495-497) the hybridoma method of at first describing is prepared, and perhaps can be prepared (seeing United States Patent (USP) 4816567) by the recombinant DNA method." monoclonal antibody " by Clackson etc. (Making antibody fragments using phage display libraries[J] .Nature, 1991:624-628) and Marks etc. (By-passing immunization:Human antibodies from V-gene libraries displayed on phage[J] .Journal of Molecular Biology, 1991:581-597) described technology is separated from phage antibody library.
The polyclonal antibody of using according to the utility model can by Chen Xueqing etc. (immunology common experimental method .[M], 2000:15-26) prepare by immune animal.
SPA of the present utility model, Protein G be by prokaryotic expression cloning recombination, by J. Sa nurse Brooker etc. (molecular cloning experiment guide .[M], 2002:1228-1232) the escherichia coli prokaryotic expression cloned gene of Miao Shuing.
The application of the anti-ribosomes P0 of colloidal gold chromatography of the present utility model antibody test test paper, it is an anti-ribosomes P0 antibody in the qualitative detection human serum, the early stage systemic loupus erythematosus of auxiliary diagnosis.
The antigen protein that the utility model is expressed genetic engineering bacterium is incorporated in the test strips first, realized the detection performance of high specific, high sensitivity, pin-point accuracy, can satisfy the rapid screening SLE in market, for patient's diagnoses and treatment early provides condition, simultaneously, also can satisfy the demand of basic unit laboratory, instant detection, bedside detection.
Detection principle of the present utility model is specially the recombinant expressed ribosomes P0 antigen protein of selecting affinitive layer purification for use, gold labeling antibody a and gold mark rabbit igg are as the colloid gold label compound, be sprayed at pad, utilize indirect method to detect and whether contain anti-ribosomes P0 antibody in the blood serum sample.During detection, sample along with the chromatography swimming to pad and soak into the colloid gold label compound, human IgG wherein and golden labeling antibody a are in conjunction with forming human IgG-Jin labeling antibody a compound, because capillary effect, this person IgG-gold labeling antibody a compound along the coated film swimming forward, if in the blood serum sample anti-ribosomes P0 antibody is arranged, this person IgG-gold labeling antibody a compound and the antigen protein generation specific immunity association reaction of bag quilt on nitrocellulose filter, form golden labeling antibody a-human IgG-ribosomes P0 antigen protein triplet compound and be trapped within on the detection line, enrichment forms darker aubergine band gradually; Because capillary effect continues swimming forward, gold mark rabbit igg be coated on goat anti-rabbit igg on the nature controlling line and special immune response takes place be trapped, be enriched in the darker aubergine band of formation on the nature controlling line gradually, unnecessary unconjugated material continues chromatography to adsorptive pads, the positive findings that is judged to of band therefore all occurs at detection line and nature controlling line; If do not contain anti-ribosomes P0 antibody in the blood serum sample, when gold labeling antibody a arrives detection line, not with the antigen protein generation immune response that is coated on the detection line, therefore at the detection line place aubergine band does not appear, gold labeling antibody a continues swimming and arrives adsorptive pads forward, and special immune response is taken place with bag in nature controlling line place goat anti-rabbit igg forward and is trapped in gold mark rabbit igg continuation swimming, be enriched in gradually and form the aubergine band on the nature controlling line, therefore only occurring band in Quality Control is judged to negative findings.
Compare the utility model advantage with conventional detection:
1. uniqueness of the present utility model is that the ribosomes P0 antigen protein first Application of dna recombinant expression is in colloid gold chromatographic test paper, improved its detection sensitivity greatly, but gone out anti-all positive sample of ribosomes P0 antibody (can detect sample) greater than 25RU/ml by the colloid gold test paper rapid screening.
2. the utility model has the advantages that production cost is low.The required core reagent of anti-ribosomes P0 detection of antibodies test paper provided by the utility model is the promptly anti-human IgG of antibody A among the golden labeling antibody a or SPA or PROTEIN G, golden labeling antibody C, antibody B, antigen protein, its wall scroll test paper agents useful for same amount is few, and can be by buying commercialization reagent or self-control, antigen protein derives from homemade purifying gene engineering antigen protein.
3. compare with the disclosed additive method that is used for anti-ribosomes P0 antibody test, test paper of the present utility model have many additive methods the advantage that can not compare, as detection time short (5～10min); Without any need for specific apparatus, can realize that bedside detects and outpatient service detects immediately; Easy and simple to handle, only need single step reaction, operating personnel need not training, and it is low to detect cost; Temperature is not had specific (special) requirements, need not freezingly, store convenient transportation, room temperature can be preserved 24 months.
Description of drawings
Fig. 1 is a side structure synoptic diagram of the present utility model.
Fig. 2 is a testing result synoptic diagram of the present utility model.
Wherein:
Fig. 2 a is depicted as: behind the application of sample, reaction 3～5min can see on detection zone D and the E relevant position, control zone and the aubergine band occurs;
Fig. 2 b is depicted as: when the aubergine band all appears in control zone E and detection zone D, the result is positive, illustrates to contain anti-ribosomes P0 antibody in the serum;
Fig. 2 c is depicted as: as only an aubergine band occurring at control zone E, the aubergine band does not appear in detection zone D, and the result is negative, illustrates not contain anti-ribosomes P0 antibody in the serum;
Fig. 2 d, 2e are depicted as: the aubergine band do not occur as control zone E, no matter whether detection zone D has band to occur, and illustrates that all test paper lost efficacy.
Embodiment
The anti-ribosomes P0 of colloidal gold immunity chromatography described in the utility model antibody test test paper, as shown in Figure 1, as shown in Figure 1, this test paper is to paste cellulose nitrate coated film 3, pad 2, sample pad 1, adsorptive pads 6 in turn mutually by a side direction opposite side on base plate 7 overlap joint.
Be coated with golden labeling antibody a layer and golden labeling antibody b layer on the pad 2, the antibody A of golden labeling antibody a layer is goat anti-rabbit igg gold labeling antibody or mouse-anti human IgG gold labeling antibody or golden labeling antibody of staphylococcal protein A (SPA) or streptococcal protein G gold labeling antibody; Antibody B in the gold labeling antibody b layer is a rabbit igg.
Cellulose nitrate coated film 3 is provided with detection line 4 and nature controlling line 5, and detection line 4 is coated with ribosomes P0 antigen protein layer, and nature controlling line 5 is coated with golden labeling antibody c layer, and the antibody in the golden labeling antibody c layer is goat anti-rabbit igg.
Below in conjunction with specific embodiments and the drawings, further set forth the utility model.
The preparation of embodiment 1 ribosomes P0 antigen protein
The ribosomes P0 antigen protein that is applied to this test paper is to make up recombination by gene clone technology, and adopting prokaryotic expression technology successful expression to go out then all is the ribosomes P0 antigen protein in people source.Wherein, ribosomes P0 antigen protein derives from the purifying gene engineering antigen protein.
Antibody A and antibody C, antibody B prepare with following method.Wherein the anti-human IgG in the antibody A, antibody C and antibody B generally can by on the animal in repeatedly subcutaneous (sc) or peritonaeum the immunogene and the adjuvant of (ip) injection purifying produce.
By being mixed with Freund ' the s Freund's complete adjuvant of 3 times of volumes, 0.05mg～1mg immune formulation (respectively at goat or mouse) obtains injection solution, with the multi-section position injection in animal skins of this injection solution, after one month with animal with Freund ' the s Freund's complete adjuvant mixed liquor of 1/5 to 1/10 human IgG of originally measuring through the animal hypodermic injection of multi-section position and booster immunization.With the animal bloodletting, measure the anti-human IgG titre of serum after 7～14 days.The animal booster immunization is reached plateau until titre.The method of producing polyclonal antibody has been described in many immunology textbooks, for example, Chen Xueqing etc. " immunology common experimental method ".By reclaiming splenocyte and make cell immortalityization from the animal of quilt immunity, for example by merging with the myeloma cell or transforming by Epstein-Barr virus, and screening can be expressed the monoclonal antibody (Kohler of purpose antibody, Milstein.Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion [J] .European Journal of Immunology, 1976:501-511).
Can prepare reorganization staphylococcal protein A and streptococcal protein G in the antibody A by the escherichia coli prokaryotic expression cloned gene, concrete operation method referring to J. Sa nurse Brooker etc. (molecular cloning experiment guide .[M], 2002:1228-1232), or buy commercial reorganization staphylococcal protein A or streptococcal protein G.
The colloidal gold solution preparation
HAuCl with 0.01%
4Solution is heated to boiling, adds every 100mL HAuCl rapidly
4Solution adds an amount of reductant solution, and color is from blueness, and is light blue then, blue, and heating occurs redly again, boils 7～10min and occurs transparent orange red.Filter with ultrafiltration or miillpore filter (0.45 μ m) again, to remove polymkeric substance and other impurity that may sneak into wherein.The collaurum outward appearance for preparing should be pure, bright, do not have precipitation and floating thing, abandons when grease and a large amount of black particle shape sediment appear in liquid level.
Wherein employed reductive agent can preferably use trisodium citrate for trisodium citrate (Frens 1973), tannic acid-trisodium citrate (Slot and Gueeze 1985), white phosphorus, more preferably uses 1% trisodium citrate.
Wherein used glass container should definitely clean, with preceding need through pickling, silication.Its water should be the deionization ultrapure water, and resistivity reaches 18.2M Ω.
In the colloidal gold solution preparation process, the compound method of each solution is as follows:
1.HAuCl
4Preparation: with ultrapure water dissolved chlorine auric acid, be made into 1% solution, put 4 ℃ standby, the term of validity four months.1000mL 1%HAuCl
4Solution formula: 10g HAuCl
4, ultrapure water is settled to 1000mL.
The preparation of 2.1% trisodium citrate: the preparation of 1% trisodium citrate (Sodium Citrate): with ultrapure water dissolving Sodium Citrate, be made into 1% solution, 0.22 μ m membrane filtration mistake, now with the current.
The preparation method of the anti-ribosomes P0 of colloidal gold immunity chromatography of the present utility model antibody test test paper specifically comprises the steps:
(1) adopt the method for embodiment 1 to prepare ribosomes P0 antigen protein;
(2) preparation of goat anti-rabbit igg gold labeling antibody:
Regulate collaurum pH7.0～9.0 of embodiment 3 preparations with 0.1M sal tartari, slowly add 4～25 μ g goat anti-rabbit iggs by every milliliter of colloidal gold solution, stir 10～30min, add BSA then to final concentration 0.5～1%, stir 10～30min, centrifugal, abandon supernatant, to precipitate with cleansing solution washing 2～3 times, last will precipitate resuspended with the preservation liquid of 1/10th initial volumes, put 4 ℃ standby;
(3) preparation of cellulose nitrate coated film 3, with coated film damping fluid dilution ribosomes P0 antigen protein to concentration is 1.0～1.5mg/mL, adjust the BIO-Dot instrument, be sprayed at nitrocellulose filter (NC) and go up detection line 4 places, near pad 2 ends, apart from pad 2 about 9.5mm, make Cenp-B antigen protein bag by on the detection line 4 of cellulose nitrate coated film;
Be cushioned liquid with bag goat anti-rabbit igg is diluted to 0.8～1.5mg/mL, be sprayed at nature controlling line 5 places that nitrocellulose filter (NC) is gone up close adsorptive pads 6 with 1～10 μ l/cm with the BIO-Dot instrument, apart from adsorptive pads 6 about 9mm.Detection line 4 and 5 liang of about 5～8mm of linear distance of nature controlling line, the spray line is answered even thickness.37 ℃ of oven dry encapsulate standby.
It can be borate that the bag of its use is cushioned liquid, carbonate, phosphate, Tris-HCl or Tris-phosphate, acetate, barbital, or the like, the purpose of its damping fluid makes the albumen bag also firmly be wrapped quilt in the NC film for certain pH and ionic strength are provided, and its pH of buffer value generally is about in 6～9.5 scopes, be preferably in 6.5～7.5 the neutral buffered scope, and most preferably the pH value of damping fluid is in 7.0～7.4 scopes.Damping fluid is preferably phosphate.
Nitrocellulose filter wherein (NC) can be any commercialization nitrocellulose filter, S﹠amp; SAE99, whatman 8 μ m, millipore M135, sartorius CN140 etc.The concrete NC film that uses is not a key of the present utility model, but in each mensuration, above-mentioned several NC films can be used as preferably.The film that the different damping fluids that contain the different surfaces activating agent that different manufacturers uses are handled, with used detection line antibody-solutions affinity in various degree gap is arranged, also can largely cause lines inhomogeneous, the traction or the phenomenon of disperse, therefore utilization assembling test paper is selected preferred NC film.
(1) preparation of goat anti-human igg's gold labeling antibody: collaurum pH8.0～9.0 of regulating embodiment 3 preparations with 0.1M sal tartari, slowly add 8～12 μ m goat anti-human iggs by every milliliter of colloidal gold solution, stir 10～30min, add BSA then to final concentration 0.5～1%, stir 10～30min, centrifugal, abandon supernatant, to precipitate with cleansing solution washing 2～3 times, last will precipitate resuspended with the preservation liquid of 1/10th initial volumes, put 4 ℃ standby;
(2) preparation of rabbit igg gold labeling antibody: collaurum pH value to 7.0～8.0 of regulating embodiment 3 preparations with 0.1M sal tartari, slowly add 8～12 μ g rabbit iggs by every milliliter of colloidal gold solution, stir 10～30min, add BSA then to final concentration 0.5～1%, stir 10～30min, centrifugal, abandon supernatant, to precipitate with cleansing solution washing 2～3 times, last will precipitate resuspended with the preservation liquid of 1/10th initial volumes, put 4 ℃ standby.
(3) preparation of pad: the polyester film was soaked 30 minutes through damping fluid, 37 ℃ of oven dry, after goat anti-human igg gold labeling antibody and rabbit igg gold labeling antibody mixed according to a certain percentage, use the BIO-Dot instrument, consumption with 0.5～4 μ l/cm is sprayed on the pretreated polyester film, and 25 ℃～37 ℃ dryings get pad 2 after to be dried the finishing, pad 2 vacuum packagings, put 2 ℃～8 ℃ standby.Place under 2 ℃～8 ℃ the environment standby;
In the preparation process of pad, operable damping fluid comprises following several:
(a) contain 1%PVA, 0.71%Na
3PO
4, 1%BSA, 0.05%NaN
3, 0.1%TritonX-100;
(b)1％PVA、1％BSA、0.05％PROCLIN
TM300、0.1％TritonX-100，pH7.0PBS；
(c)1％PVA、1％BSA、0.05％PROCLIN
TM300，pH7.0PBS；
(d) contain 1%PVA, 0.71%Na
3PO
4, 1%BSA, 0.05%NaN
3, 0.1%Tween-20;
(e) contain 1%PVA, 0.71%Na
3PO
4, 1%BSA, 0.05%NaN
3, 0.1%Tween-20, pH7.0PBS;
Its preferred damping fluid is damping fluid (d), because it has the ultimate resolution of difference yin and yang attribute sample.PROCLIN
TM300 and NaN
3Play antisepsis, and Tween-20 have decontamination and hydrophilic interaction.
Blending ratio between goat anti-human igg's gold labeling antibody and the rabbit igg gold labeling antibody can be carried out according to following method:
Substantially determine the OD20 of rabbit igg gold labeling antibody by preliminary experiment, be sprayed on the pretreated polyester film with BIO-Dot discharge rate 1 μ l/cm, with 0.01MPBS is sample-loading buffer, and the band of the color intensity that can obtain expecting determines that the application OD discharge rate of rabbit igg gold labeling antibody is 1 μ l.
Subsequently goat anti-human igg's gold labeling antibody is carried out gradient dilution to final concentration OD100,80,60,40,20, then rabbit igg gold labeling antibody is diluted to final concentration OD20, is that 3 μ l/cm are sprayed on the polyester film of handling well with BIO-Dot with above goat anti-human igg's gold labeling antibody and rabbit igg gold labeling antibody potpourri discharge rate, cellulose nitrate coated film 3, pad 2, sample pad 1, the adsorptive pads 6 of preparation are pasted on the base plate 7 successively, are debugger object with positive serum, critical reference value serum, negative serum.Judgment basis: both band color intensities of the detection line 4 of positive serum and nature controlling line 5 are consistent to be foundation, and critical reference value serum can occur, and negative serum does not have that OD value that band occurs, and is the application quantity of this batch.Drawing OD20～40 by this test comparatively meets the requirements.
Glass fibre membrane is pressed the 45mL/ sheet, evenly spills with damping fluid and be applied on the glass fibre membrane, after 37 ℃ of oven dry sample pad, sample pad encapsulates with aluminium foil bag, and is standby;
This step can with damping fluid comprise following several:
(a)0.05M?Borax、0.01MPBS(pH7.0)、0.1％Sodium?Casein、1％PEG20000、2％BSA、0.05％NaN
3；
(b)0.05M?Borax、0.01MPBS(pH7.0)、0.1％Sodium?Casein、1％PEG20000、2％Casein、0.05％NaN
3；
(c)0.05M?Tris-cl(pH7.0)、0.01MPBS、0.1％Sodium?Casein、1％PEG20000、2％Casein、0.05％NaN
3。
Preferred damping fluid is damping fluid (a), because it has the ultimate resolution of difference yin and yang attribute sample, NaN
3Play antisepsis.
At first carry out the starting material pre-cut:
Cutting of sample pad: with guillotine sample pad is cut into the promptly long 28cm of the base plate equal length made from PVC, wide 2.4cm puts between drying shed standby.
Cutting of adsorptive pads: with trimmer thieving paper is cut into the promptly long 28cm of the base plate equal length made from PVC, wide 3cm makes adsorptive pads, puts between drying shed standby.
Cutting of pad: with guillotine pad is cut into the promptly long 28cm of the base plate equal length made from PVC, wide 2.4cm puts between drying shed standby.
Cutting of cellulose nitrate coated film: with trimmer the cellulose nitrate coated film is cut into the promptly long 28cm of the base plate equal length made from PVC, wide 1cm, it is standby to put drying shed.
Cellulose nitrate coated film 3, pad 2, sample pad 1, adsorptive pads 6 are stacked gradually on the base plate 7 that the PVC plastics are made by shown in Figure 1, form big plate.Composing room's temperature should be controlled at 25 ℃～37 ℃, humidity 20%～30%.
Slitting: big plate is cut into single part with cutting cutter, everyone part width is cut into the width of 2.5mm～4mm according to certain requirement, sampling observation at random, sensitivity can detect indoor quality-control sample (promptly weak positive sample), band colour developing degree reaches the d as Fig. 2, and specific band nothing but, then product becomes specification product by the Quality Control regulation.
Assembling, packing: the test paper that 1 person-portion has been cut is assembled in the test card of getting ready, makes the sample pad of the corresponding test paper of application of sample window, corresponding detection zone of display window and control zone as a result, and composing room's temperature should be controlled at 25 ℃～37 ℃, humidity 20%～30%.Be encapsulated in the outer bag with drying agent, instructions, sample pipetting volume device again, keep in Dark Place in 4～25 ℃.
In the preparation process of the anti-Cenp-B antibody test of above-mentioned colloidal gold chromatography test paper, the collocation method of each solution is as follows:
1.0.1M the preparation of sal tartari: with ultrapure water preparation, 0.22 μ m membrane filtration mistake, put 4 ℃ standby, the term of validity one month.1000mL 0.1M K
2CO
3Solution formula: 13.8g K
2CO
3Ultrapure water is settled to 1000mL.
The preparation of 2.10%BSA: with ultrapure water preparation, 0.05% Sodium azide (NaN
3), 0.22 μ m membrane filtration mistake, put 4 ℃ standby, two weeks of the term of validity.1000mL 10%BSA solution formula: 100g BSA, 0.5g NaN
3Ultrapure water is settled to 1000mL.
3, bag is cushioned the preparation of liquid: 9g Nacl, 1.15g Na
2HPO
4, 0.23g NaH
2PO
4, 10g Sucrose, 0.5g EDTA be dissolved in the 1L ultrapure water, filter place 4 ℃ standby.
4. cleansing solution is also promptly preserved the preparation of liquid:
2%BSA, 0.05% (NaN
3), 0.01M pH7.2PBS, 0.22 μ m membrane filtration mistake, put 4 ℃ standby, two weeks of the term of validity.Formula of liquid is preserved in the washing of 1000mL mark: 20g BSA, 0.5g NaN
3, 0.01MpH7.2PBS is settled to 1000mL.
5. the preparation of gold mark dilution:
The preparation of 1000mL dilution: 2.423g tris, 10g BSA, 0.2g NaN
3Be dissolved in the ultrapure water, transfer pH8.0, constant volume is to 1000mL.
After with dilution gold mark being diluted to working concentration, add the trehalose of 20%Sucrose and 5%.
The preparation method of the anti-ribosomes P0 of the colloidal gold immunity chromatography of this embodiment antibody test test paper, its step is basic identical with embodiment 4, just the preparation process of the goat anti-human igg of (1) gold labeling antibody replaces with the preparation of the golden labeling antibody of staphylococcal protein A (SPA) in the step 2 with this embodiment, and is specific as follows:
Regulate collaurum pH value to 5.0～6.5 with pH9.0 0.2M borate buffer, slowly add 10～15 μ g SPA albumen by every milliliter of colloidal gold solution, stir 10～30min, add BSA then to final concentration 0.5～1%, stir 10～30min, centrifugal, abandon supernatant, to precipitate with cleansing solution washing 2～3 times, last will precipitate resuspended with the preservation liquid of 1/10th initial volumes, put 4 ℃ standby.
Blending ratio between golden labeling antibody of staphylococcal protein A (SPA) in this embodiment step 2 and the rabbit igg gold labeling antibody can be carried out according to the method for embodiment 4.
The preparation method of the anti-ribosomes P0 of the colloidal gold immunity chromatography of this embodiment antibody test test paper, its step is basic identical with embodiment 4, just the preparation process of the goat anti-human igg of (1) gold labeling antibody replaces with the preparation of mouse-anti human IgG gold labeling antibody in the step 2 with this embodiment, and is specific as follows:
Regulate collaurum pH value to 7.0～8.0 with 0.1M sal tartari, slowly add 8～12 μ g mouse-anti human IgGs by every milliliter of colloidal gold solution, stir 10～30min, add BSA then to final concentration 0.5～1%, stir 10～30min, centrifugal, abandon supernatant, to precipitate with cleansing solution washing 2～3 times, last will precipitate resuspended with the preservation liquid of 1/10th initial volumes, put 4 ℃ standby.
Blending ratio between mouse-anti human IgG gold labeling antibody in this embodiment step 2 and the rabbit igg gold labeling antibody can be carried out according to the method for embodiment 4.
The preparation method of the anti-ribosomes P0 of the colloidal gold immunity chromatography of this embodiment antibody test test paper, its step is basic identical with embodiment 4, just the preparation process of the goat anti-human igg of (1) gold labeling antibody replaces with the preparation of streptococcal protein G gold labeling antibody in the step 2 with this embodiment, and is specific as follows:
Regulate collaurum pH value to 5.0～6.5 with pH9.0 0.2M borate buffer, slowly add 10～15 μ g streptococcal protein Gs by every milliliter of colloidal gold solution, stir 10～30min, add BSA then to final concentration 0.5～1%, stir 10～30min, centrifugal, abandon supernatant, to precipitate with cleansing solution washing 2～3 times, last will precipitate resuspended with the preservation liquid of 1/10th initial volumes, put 4 ℃ standby.
Blending ratio between streptococcal protein G gold labeling antibody in this embodiment step 2 and the rabbit igg gold labeling antibody can be carried out according to the method for embodiment 4.
The utility model is incorporated into the anti-ribosomes P0 of colloidal gold chromatography antibody test test paper with recombinant expressed ribosomes P0 antigen protein, can realize the anti-ribosomes P0 detection of antibodies in the blood sample, can be fast, the early stage systemic loupus erythematosus of auxiliary diagnosis easily.
Embodiment 8
Sample process
Get whole blood 1～5ml, natural aggegation is after 5 minutes, and 3000～5000g/5min～10min gets supernatant and promptly obtains testing sample solution, has the above testing sample solution of 100 μ l at least.
Draw above serum 50～70 μ l samples in sample pad with micro sample adding appliance, slowly application of sample.Perhaps with suction pipe serum sample is slowly dripped 3～5 on sample pad, 5～10min observations situation occurs according to band and comes interpretation yin and yang attribute result.
Embodiment 9
The detection of kit and clinical performance assessment
The antibody A of the golden labeling antibody a of the anti-ribosomes P0 of collaurum of the present utility model antibody test test paper is preferably SPA, and the antibody B of antibody b is a rabbit igg, and the antibody of antibody c is goat anti-rabbit igg, and the clinical performance that its test paper is carried out carries out following assessment.
1. stability test
1.1 37 ℃ of accelerated stabilities
Place 37 ℃ to carry out accelerated tests on test paper, every day, taking-up was tested with indoor quality-control product, and the withinrun precision of the yin and yang attribute coincidence rate by yin and yang attribute reference material (each 10 parts) is judged the stability of test paper.The result shows after 4 months, and the testing result of quality-control product meets expection, and the yin and yang attribute coincidence rate of each yin and yang attribute reference material is 100%.The yin and yang attribute reference material is 10 parts of anti-ribosomes P0 antibody positive serum and 10 parts of anti-ribosomes P0 negative antibody serum.
1.2 4 ℃ of stability experiments
2. diagnostic sensitivity
Collect 100 parts of serum that are diagnosed as primary bile hepatitis (SLE) patient from clinical, the operation steps that goes up to specifications with homemade colloid gold test paper detects the SLE patients serum who collects above.Statistics is as follows behind the 5min:
According to the result who adds up above, according to the detection to the SLE patients serum of 100 parts of affirmations, the sample size that can find anti-ribosomes P0 antibody positive is 29 examples, and negative sample quantity is 71 examples.Therefore by calculating:
Diagnosis sensitivity (%)=29/ (29+71) * 100%=29%
3. specificity
Collect each 300 parts of healthy blood donor's serum and non-patient SLE (comprise other autoimmune diseases such as rheumatoid arthritis and exempt from anti-ribosomes P0 antibody human certainly) serum from clinical, the operation steps that goes up to specifications with homemade colloid gold test paper detects the healthy blood donor that collects above and non-patient's SLE serum.Statistics is as follows behind the 5min:
According to statistics to the detection of each 300 parts of serum of non-patient SLE and healthy blood donor, discovery records anti-ribosomes P0 negative antibody in the healthy blood donor sample size is 295 examples, but not the sample size of SLE patients serum's anti-ribosomes P0 negative antibody is 291 examples.Therefore by calculating:
(healthy blood donor) specificity (%)=295/300 * 100%=98.33%
(non-SLE patients serum) specificity (%)=291/300=97%
600 routine control groups (comprising healthy blood donor and non-SLE patients serum)
Specificity (%)=586/600=97.66%
4. diagnostic accuracy
According to the statistics of top specificity and diagnostic sensitivity, can obtain following this summary table:
Can see that according to top statistical form for the patients serum who confirms SLE, detecting the positive sample number that obtains is 29 examples, in 600 routine healthy blood donors and non-SLE patients serum, detecting negative sample is 587 examples.
That is: diagnostic accuracy=(29+587)/700=88%
5. inaccuracy in criticizing
Select certain a collection of test paper of production for use, select each portion of serum (strong, in, weak, feminine gender) of four kinds of variable concentrations simultaneously, every part of serum is done 10 repetitions, observations behind the 5min.
Learn that according to top result the anti-ribosomes P0 of the same a collection of colloidal gold chromatography antibody test test paper of production detects the serum of the variable concentrations of four parts of dilutions, each sample repeats 10 times, all can tell yin and yang attribute accurately, obtains consistent yin and yang attribute result.
Therefore, draw to draw a conclusion: there is not batch interior inaccurate phenomenon in the anti-ribosomes P0 of colloidal gold chromatography antibody test test paper.
6. inaccuracy between criticizing
Select the three batches of anti-ribosomes P0 of different colloidal gold chromatographies antibody test test paper of production for use, select each portion of serum (strong, in, weak, feminine gender) of four kinds of variable concentrations simultaneously, every part of serum repeats observations behind the 5min 10 times.
Learn that according to top result the three batches of anti-ribosomes P0 of colloidal gold chromatography antibody test test paper of the different batches of production detect four parts of different serum, each detects and repeats 10 times, all can tell yin and yang attribute accurately, obtains consistent yin and yang attribute result.
Therefore, draw to draw a conclusion: inaccurate phenomenon between the anti-ribosomes P0 of colloidal gold chromatography antibody test test paper is criticized less than existence.
7. the contrast test of the linear immunoassay detection kit of antinuclear antibodies spectrum of the product-IMTEC Autoimmundiagnostika GmbH that learns with similar test item distinct methods.From clinical collection 100 parts of patient's sample serum at random, detect with linear immunoassay detection kit of the antinuclear antibodies spectrum of IMTEC Autoimmundiagnostika GmbH and the anti-ribosomes P0 of self-control colloidal gold chromatography antibody test test paper respectively, obtain following result:
Positive coincidence rate: 45/46 * 100%=97.82%
Negative match-rate: 50/54 * 100%=92.59%
Total coincidence rate: (45+50)/100=95%
According to top statistics, the total coincidence rate of the linear immunoassay detection kit of the antinuclear antibodies spectrum of self-control colloidal gold chromatography anti-ribosomes P0 antibody test test paper and IMTEC Autoimmundiagnostika GmbH can reach 95%.
More than be to description of the present utility model and non-limiting, based on other embodiment of the utility model thought, all among protection domain of the present utility model.
Claims (7)
1. the anti-ribosomes P0 of colloidal gold chromatography antibody test test paper, include sample pad (1), pad (2), cellulose nitrate coated film (3), adsorptive pads (6), described sample pad (1), pad (2), cellulose nitrate coated film (3), adsorptive pads (6) are overlapped mutually to the opposite side of described base plate (7) successively by a side of base plate (7) and stick on the described base plate (7), it is characterized in that:
Described pad (2) is coated with golden labeling antibody a layer and golden labeling antibody b layer;
Described cellulose nitrate coated film (3) is provided with detection line (4) and nature controlling line (5), and described detection line (4) is coated with ribosomes P0 antigen protein layer, and described nature controlling line (5) is coated with golden labeling antibody c layer.
2. the anti-ribosomes P0 of colloidal gold chromatography according to claim 1 antibody test test paper is characterized in that: the antibody A in the described golden labeling antibody a layer is one or more among anti-human IgG monoclonal antibody, anti-human IgG polyclonal antibody, staphylococcal protein A SPA, the streptococcal protein G Protein G.
3. the anti-ribosomes P0 of colloidal gold chromatography according to claim 2 antibody test test paper is characterized in that: described anti-human IgG polyclonal antibody is a kind of in mouse source, Ma Yuan, Yang Yuan, rabbit source or the cavy source; Described anti-human IgG monoclonal antibody is a kind of in mouse source or the rabbit source.
4. the anti-ribosomes P0 of colloidal gold chromatography according to claim 1 antibody test test paper, it is characterized in that: the antibody A among the described golden labeling antibody a is a staphylococcal protein A.
5. the anti-ribosomes P0 of colloidal gold chromatography according to claim 1 antibody test test paper, it is characterized in that: the antibody B in the described golden labeling antibody b layer and the antibody C in the golden labeling antibody c layer be a kind of in monoclonal antibody or the polyclonal antibody simultaneously simultaneously or, and the antibody C in antibody B in the wherein golden labeling antibody b layer and the golden labeling antibody c layer specificity can take place in conjunction with forming immune complex.
6. the anti-ribosomes P0 of colloidal gold chromatography according to claim 5 antibody test test paper, it is characterized in that: described polyclonal antibody is a kind of in mouse source, Ma Yuan, Yang Yuan, rabbit source or the cavy source, and described monoclonal antibody is a kind of in mouse source or the rabbit source.
7. the anti-ribosomes P0 of colloidal gold chromatography according to claim 1 antibody test test paper is characterized in that: the ribosomes P0 antigen protein layer of ribosomes P0 antigen protein layer for obtaining by the prokaryotic expression cloned gene of bag quilt on the described detection line.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011200310809U CN202083693U (en) | 2011-01-28 | 2011-01-28 | Test paper for detecting anti-ribosomal P0 antibody by adopting colloidal gold chromatographic assay |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011200310809U CN202083693U (en) | 2011-01-28 | 2011-01-28 | Test paper for detecting anti-ribosomal P0 antibody by adopting colloidal gold chromatographic assay |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN202083693U true CN202083693U (en) | 2011-12-21 |
Family
ID=45344319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011200310809U Expired - Lifetime CN202083693U (en) | 2011-01-28 | 2011-01-28 | Test paper for detecting anti-ribosomal P0 antibody by adopting colloidal gold chromatographic assay |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN202083693U (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102621309A (en) * | 2011-01-28 | 2012-08-01 | 上海科新生物技术股份有限公司 | Colloidal gold chromatography anti-ribosomal P0 antibody detection test paper and preparation method thereof |
| CN105891468A (en) * | 2016-04-08 | 2016-08-24 | 四川新健康成生物股份有限公司 | Sample release pad treatment solution |
-
2011
- 2011-01-28 CN CN2011200310809U patent/CN202083693U/en not_active Expired - Lifetime
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102621309A (en) * | 2011-01-28 | 2012-08-01 | 上海科新生物技术股份有限公司 | Colloidal gold chromatography anti-ribosomal P0 antibody detection test paper and preparation method thereof |
| CN105891468A (en) * | 2016-04-08 | 2016-08-24 | 四川新健康成生物股份有限公司 | Sample release pad treatment solution |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102062777B (en) | Hepatopathy detecting test paper by colloidal gold chromatography and preparation method thereof | |
| CN101988924B (en) | Test strip for detecting anti-cyclic citrullinated peptide antibody in blood and preparation method | |
| CN109085333A (en) | A kind of preparation, detection kit and the preparation method of rheumatoid factor antigen | |
| CN102621308B (en) | Colloidal gold chromatography anti-Jo-1 antibody detection test paper and preparation method thereof | |
| CN104297465A (en) | Anti-OmpC antibody detection test paper preparation method and purpose thereof | |
| CN105628932A (en) | SAA (serum amyloid A) immunochromatographic test strip and preparation method and test method thereof | |
| CN101650368A (en) | Method for testing zearalenone toxin by using colloidal gold immunochromatography assay | |
| CN102621315B (en) | Colloidal gold chromatography anti-Ro52 antibody detection test paper and preparation method thereof | |
| CN202083693U (en) | Test paper for detecting anti-ribosomal P0 antibody by adopting colloidal gold chromatographic assay | |
| CN102621311B (en) | Colloidal gold chromatography anti-SSB antibody detection test paper and preparation method thereof | |
| CN104297488A (en) | Anti-CBir1 antibody detection test paper preparation method and purpose thereof | |
| CN202083695U (en) | Anti-nucleosome antibody detecting test paper adopting colloidal gold chromatography | |
| CN202141726U (en) | Anti-Jo-1 antibody test paper with colloidal gold immunochromatography | |
| CN104764881A (en) | Preparation method and application of anti-MPO-ANCA antibody immunity chromatography test paper | |
| CN202083698U (en) | Colloidal gold chromatographic Ro52 antibody resistance detection test paper | |
| CN202083696U (en) | Anti-U1-RNP antibody detecting test paper adopting colloidal gold chromatography | |
| CN102621312B (en) | Colloidal gold chromatography hepatopathy detection test paper and preparation method thereof | |
| CN202083697U (en) | Anti-SSB antibody detecting test paper adopting colloidal gold chromatography | |
| CN104764884A (en) | Preparation method and application of anti-alpha-enolase antibody chromatography test strip | |
| CN104198698A (en) | CUB and zona pellucida-like domains-containing protein 1 (CUZD1) antibody chromatography test strip and usage thereof | |
| CN102621313B (en) | Colloidal gold chromatography anti-Sp100 antibody detection test paper and preparation method thereof | |
| CN202083694U (en) | Anti-Cenp-B antibody detecting test paper adopting colloidal gold immunochromatography | |
| CN102621309B (en) | Colloidal gold chromatography anti-ribosomal P0 antibody detection test paper and preparation method thereof | |
| CN102621310B (en) | Colloidal gold chromatography anti-U1-RNP antibody detection test paper and preparation method thereof | |
| CN104330569B (en) | A kind of test strips of quick detection antibody |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CX01 | Expiry of patent term | ||
| CX01 | Expiry of patent term |
Granted publication date: 20111221 |